The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53.

KAI1 is a tumor metastasis suppressor gene that is capable of inhibiting the metastatic process in animals. The expression of the KAI1 gene also is found to be down-regulated during the tumor progression of prostate, breast, lung, bladder, and pancreatic cancers in humans, and this down-regulation appears to be at or posttranscription level. We have found that the tumor suppressor gene p53 can directly activate the KAI1 gene by interacting with the 5' upstream region. The p53 responding region is located at approximately 860 bases upstream of the transcriptional initiation site, and it contains a typical tandem repeat of the p53 consensus-binding sequence. A gel-shift mobility analysis showed that this sequence indeed had the ability to bind to the purified p53 protein. Mutations of this sequence abolished the responsiveness to p53 and also the binding ability to the p53 protein. Furthermore, immunohistochemical analysis of 177 samples of human prostate tumors revealed that the expression of the KAI1 gene was correlated strongly to that of the p53 gene and that the loss of these two markers resulted in poor survivals of patients. Our data indicate a direct relationship between p53 and KAI1 genes and suggest that the loss of p53 function, which is commonly observed in many types of cancer, leads to the down-regulation of the KAI1 gene, which may result in the progression of metastasis.

[1]  P. Jackson,et al.  Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  Y. Nakamura,et al.  Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein), a gene induced by p53. , 1997, Genomics.

[3]  M. Cohen,et al.  Fas-mediated apoptosis in human prostatic carcinoma cell lines. , 1997, Cancer research.

[4]  W. Isaacs,et al.  Genomic organization of the human KAI1 metastasis-suppressor gene. , 1997, Genomics.

[5]  K. Akakura,et al.  Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. , 1996, The American journal of pathology.

[6]  H. Friess,et al.  KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. , 1996, Cancer research.

[7]  W. Isaacs,et al.  Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. , 1996, Cancer research.

[8]  J. Brooks,et al.  An uncertain role for p53 gene alterations in human prostate cancers. , 1996, Cancer research.

[9]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[10]  M. Higashiyama,et al.  Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. , 1996, Cancer research.

[11]  A. Balmain,et al.  Expression pattern of the cell adhesion molecules E‐cadherin, P‐cadherin and α6β4 integrin is altered in pre‐malignant skin tumors of p53‐deficient mice , 1996 .

[12]  J. Barrett,et al.  KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.

[13]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[14]  J. Barrett,et al.  Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. , 1994, Cancer research.

[15]  J. Roth,et al.  Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. , 1994, Journal of the National Cancer Institute.

[16]  J. E. Stenger,et al.  p53 domains: structure, oligomerization, and transformation , 1994, Molecular and cellular biology.

[17]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[18]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[19]  B. Luckow,et al.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements , 1987, Nucleic Acids Res..